Valiant Organics Ltd

Valiant Organics Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Valiant Organics Ltd

₹ 328 -0.48%
22 Nov - close price
valiantorganics.com BSE: 540145 NSE: VALIANTORG
About

Incorporated in 1984, Valiant Organics
Ltd manufactures and deals in specialty chemicals and pharma intermediates[1]

Key Points

Business Overview:[1][2][3]
VOL is is promoted by Gogri, Chedda and Gala families. It is a manufacturer and seller of specialty chemicals. It is one of the largest manufacturers of chlorophenol derivatives, Benzene derivatives, PNA, PAP, Ortho Anisidine and Para Anisidine. Company has a client base across Pharmaceuticals, Dyes & Pigments, Agrochemicals, specialty chemicals, and veterinary medications

Website BSE NSE
  • Market Cap ₹ 906 Cr.
  • Current Price ₹ 328
  • High / Low ₹ 519 / 307
  • Stock P/E
  • Book Value ₹ 260
  • Dividend Yield 0.00 %
  • ROCE 1.07 %
  • ROE -0.91 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 0.88% over past five years.
  • Company has a low return on equity of 10.0% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE Allcap BSE Commodities BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
273 288 348 266 264 250 271 202 203 141 177 168 160
226 238 291 234 222 212 219 178 188 139 179 152 159
Operating Profit 47 50 57 32 42 38 52 24 15 3 -2 16 1
OPM % 17% 17% 16% 12% 16% 15% 19% 12% 8% 2% -1% 9% 0%
2 3 2 2 2 6 3 9 4 0 -7 0 3
Interest 2 1 2 3 3 3 3 4 4 4 7 5 8
Depreciation 7 8 8 7 7 7 8 9 9 9 9 9 9
Profit before tax 41 44 49 24 34 35 44 20 6 -10 -25 2 -14
Tax % 26% 26% 25% 30% 25% 25% 23% 25% 26% -20% -20% 128% -9%
30 32 37 17 26 26 34 15 5 -8 -20 -1 -12
EPS in Rs 9.42 11.03 11.45 5.68 7.72 8.09 10.96 4.57 1.58 -2.86 -7.32 -0.22 -4.63
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
692 675 755 1,153 1,052 723 646
511 494 550 948 888 686 630
Operating Profit 181 181 205 205 164 37 17
OPM % 26% 27% 27% 18% 16% 5% 3%
8 6 6 7 13 6 -4
Interest 4 3 5 6 11 16 24
Depreciation 14 16 21 30 29 35 35
Profit before tax 171 168 185 176 137 -9 -46
Tax % 29% 25% 29% 27% 25% -3%
121 126 131 128 103 -8 -41
EPS in Rs 103.65 51.00 42.19 41.72 32.45 -3.04 -15.03
Dividend Payout % 6% 11% 12% 8% 3% 0%
Compounded Sales Growth
10 Years: %
5 Years: 1%
3 Years: -1%
TTM: -30%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -152%
Stock Price CAGR
10 Years: %
5 Years: -13%
3 Years: -33%
1 Year: -24%
Return on Equity
10 Years: %
5 Years: 16%
3 Years: 10%
Last Year: -1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 6 12 27 27 27 28 28
Reserves 254 374 475 586 662 702 689
77 140 210 364 274 257 202
112 143 165 216 276 262 255
Total Liabilities 448 669 876 1,192 1,239 1,248 1,173
150 276 510 543 670 643 637
CWIP 66 129 46 112 71 86 90
Investments 12 23 6 8 41 99 94
221 241 314 529 457 420 352
Total Assets 448 669 876 1,192 1,239 1,248 1,173

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
76 161 115 -31 238 84
-86 -184 -159 -124 -143 -65
1 27 49 167 -112 -23
Net Cash Flow -9 5 5 12 -17 -4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 75 72 76 102 88 106
Inventory Days 44 42 66 54 68 88
Days Payable 69 82 97 63 89 159
Cash Conversion Cycle 50 32 44 93 67 34
Working Capital Days 63 42 63 103 81 88
ROCE % 39% 30% 21% 14% 1%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
39.01% 39.00% 38.46% 38.43% 38.41% 38.41% 38.37% 37.90% 37.90% 37.77% 37.77% 37.77%
1.98% 1.73% 1.99% 0.68% 0.57% 0.18% 0.30% 0.19% 0.69% 1.14% 1.35% 1.34%
1.90% 1.92% 1.89% 2.13% 1.94% 0.89% 0.88% 0.92% 0.87% 0.43% 0.09% 0.08%
57.11% 57.35% 57.66% 58.78% 59.07% 60.52% 60.43% 60.99% 60.54% 60.65% 60.79% 60.80%
No. of Shareholders 31,98332,79934,53942,49743,10644,30245,84848,59849,05050,46050,02248,189

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls